Strokes management, secondary to proximal arterial occlusion, by endovascular thrombectomy (TM) is now well established. The immuno-inflammatory events of reperfusion after TM are discussed. Systemic inflammation is a major factor suggested to explain the limited recovery of the ischemic parenchyma. Understanding these phenomena is necessary before developing an immunomodulatory strategy.
Study Type
OBSERVATIONAL
Enrollment
15
Patients from 2 groups will undergo blood sample (during a blood sample for there care) and inflammation parameters will be measure the day of the stroke
Service d'Anesthésie Réanimation Hôpital - Neurologique/Groupement Est
Bron, France
Service de Neurologie vasculaire - Hôpital Neurologique/Groupement Est
Bron, France
Service de Neuroradiologie interventionnelle - Hôpital Neurologique/Groupement Est
Bron, France
Service d'Anesthésie Réanimation - Hôpital Edouard Herriot/Groupement Centre
Lyon, France
Inflammation parameters description
Inflammatory parameters such as CRP, IL-6, IL-10, HLA-DR, TNF-alpha, polymorphonuclear chemotaxis, CD-4, T-lymphocytes will be measure in blood sample
Time frame: 1 day
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.